News articles about Neptune Technologies & Bioressources (NASDAQ:NEPT) (TSE:NTB) have trended somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Neptune Technologies & Bioressources earned a news sentiment score of 0.22 on Accern’s scale. Accern also gave news coverage about the biotechnology company an impact score of 47.1899739846754 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
NEPT stock traded up $0.12 during trading hours on Wednesday, hitting $3.08. The company’s stock had a trading volume of 401,805 shares, compared to its average volume of 965,762. Neptune Technologies & Bioressources has a 52-week low of $0.70 and a 52-week high of $3.59.
About Neptune Technologies & Bioressources
Neptune Technologies & Bioressources Inc is a solution provider of omega-3’s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids.
Receive News & Ratings for Neptune Technologies & Bioressources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Technologies & Bioressources and related companies with MarketBeat.com's FREE daily email newsletter.